Hims & Hers: Q3 misses estimates and weak Q4 outlook
FROM THE WIRE · BENZINGA.COM
Hims & Hers Health Inc. (NYSE:HIMS) had a busy week that included third-quarter results that missed estimates, a new board member in Andrew Huberman and a round of analyst price target changes.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA missed quarter and weak outlook weigh on the stock's prospects.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Hims & Hers reported third-quarter results below estimates.
- 02Andrew Huberman joined the board of directors.
- 03A round of analyst price target changes followed.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets